Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer now identifies the website as revision v3.7.1 instead of v3.7.0.
    Difference
    0.0%
    Check dated 2026-10-13T10:09:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The record history gains a new revision entry labeled v3.7.0, replacing v3.6.6 and updating the historical version of the study record.
    Difference
    0.0%
    Check dated 2026-09-22T12:26:21.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page revision tag in the footer was updated from v3.6.5 to v3.6.6. This reflects a minor maintenance update to the page.
    Difference
    0.0%
    Check dated 2026-08-31T23:47:26.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The revision label in the page footer updated from v3.6.4 to v3.6.5, indicating a minor page version update. This is a metadata change that does not alter the study information displayed.
    Difference
    0.0%
    Check dated 2026-08-10T13:49:50.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The footer revision text changed from v3.6.3 to v3.6.4, indicating a new version of the site interface.
    Difference
    0.0%
    Check dated 2026-07-27T05:37:37.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    The record history now lists revision v3.6.3 as the current version, updating the page's metadata.
    Difference
    0.0%
    Check dated 2026-07-05T13:16:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.